300 related articles for article (PubMed ID: 28890203)
1. Regional aerosol deposition in the human airways: The SimInhale benchmark case and a critical assessment of in silico methods.
Koullapis P; Kassinos SC; Muela J; Perez-Segarra C; Rigola J; Lehmkuhl O; Cui Y; Sommerfeld M; Elcner J; Jicha M; Saveljic I; Filipovic N; Lizal F; Nicolaou L
Eur J Pharm Sci; 2018 Feb; 113():77-94. PubMed ID: 28890203
[TBL] [Abstract][Full Text] [Related]
2. Experimental methods for flow and aerosol measurements in human airways and their replicas.
Lizal F; Jedelsky J; Morgan K; Bauer K; Llop J; Cossio U; Kassinos S; Verbanck S; Ruiz-Cabello J; Santos A; Koch E; Schnabel C
Eur J Pharm Sci; 2018 Feb; 113():95-131. PubMed ID: 28842353
[TBL] [Abstract][Full Text] [Related]
3. An efficient computational fluid-particle dynamics method to predict deposition in a simplified approximation of the deep lung.
Koullapis PG; Hofemeier P; Sznitman J; Kassinos SC
Eur J Pharm Sci; 2018 Feb; 113():132-144. PubMed ID: 28917963
[TBL] [Abstract][Full Text] [Related]
4. Transport of ellipsoid fibers in oscillatory shear flows: Implications for aerosol deposition in deep airways.
Shachar-Berman L; Ostrovski Y; De Rosis A; Kassinos S; Sznitman J
Eur J Pharm Sci; 2018 Feb; 113():145-151. PubMed ID: 28942008
[TBL] [Abstract][Full Text] [Related]
5. One (sub-)acinus for all: Fate of inhaled aerosols in heterogeneous pulmonary acinar structures.
Hofemeier P; Koshiyama K; Wada S; Sznitman J
Eur J Pharm Sci; 2018 Feb; 113():53-63. PubMed ID: 28954217
[TBL] [Abstract][Full Text] [Related]
6. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
[TBL] [Abstract][Full Text] [Related]
7. Substance deposition assessment in obstructed pulmonary system through numerical characterization of airflow and inhaled particles attributes.
Lalas A; Nousias S; Kikidis D; Lalos A; Arvanitis G; Sougles C; Moustakas K; Votis K; Verbanck S; Usmani O; Tzovaras D
BMC Med Inform Decis Mak; 2017 Dec; 17(Suppl 3):173. PubMed ID: 29297393
[TBL] [Abstract][Full Text] [Related]
8. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
[TBL] [Abstract][Full Text] [Related]
9. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
[TBL] [Abstract][Full Text] [Related]
10. Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs.
Bäckman P; Arora S; Couet W; Forbes B; de Kruijf W; Paudel A
Eur J Pharm Sci; 2018 Feb; 113():41-52. PubMed ID: 29079338
[TBL] [Abstract][Full Text] [Related]
11. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
12. Dry powder aerosol delivery systems: current and future research directions.
Chan HK
J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
[TBL] [Abstract][Full Text] [Related]
13. A critical analysis of the CFD-DEM simulation of pharmaceutical aerosols deposition in upper intra-thoracic airways: Considerations on air flow.
Spasov GH; Rossi R; Vanossi A; Cottini C; Benassi A
Comput Biol Med; 2024 Mar; 170():107948. PubMed ID: 38219648
[TBL] [Abstract][Full Text] [Related]
14. Mice-to-men comparison of inhaled drug-aerosol deposition and clearance.
Kolanjiyil AV; Kleinstreuer C; Kleinstreuer NC; Pham W; Sadikot RT
Respir Physiol Neurobiol; 2019 Feb; 260():82-94. PubMed ID: 30445230
[TBL] [Abstract][Full Text] [Related]
15. New Approach Methodology for Assessing Inhalation Risks of a Contact Respiratory Cytotoxicant: Computational Fluid Dynamics-Based Aerosol Dosimetry Modeling for Cross-Species and In Vitro Comparisons.
Corley RA; Kuprat AP; Suffield SR; Kabilan S; Hinderliter PM; Yugulis K; Ramanarayanan TS
Toxicol Sci; 2021 Aug; 182(2):243-259. PubMed ID: 34077545
[TBL] [Abstract][Full Text] [Related]
16. In silico optimization of targeted aerosol delivery in upper airways via Inhaled Volume Tracking.
Heller-Algazi M; Nof E; Das P; Bhardwaj S; Kassinos SC; Sznitman J
Clin Biomech (Bristol, Avon); 2020 Dec; 80():105138. PubMed ID: 32798812
[TBL] [Abstract][Full Text] [Related]
17. Controlled, Parametric, Individualized, 2-D and 3-D Imaging Measurements of Aerosol Deposition in the Respiratory Tract of Asthmatic Human Subjects for Model Validation.
Fleming J; Conway J; Majoral C; Katz I; Caillibotte G; Pichelin M; Montesantos S; Bennett M
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):432-51. PubMed ID: 25859710
[TBL] [Abstract][Full Text] [Related]
18. An individualised 3D computational flow and particle model to predict the deposition of inhaled medicines - A case study using a nebuliser.
Wang Y; Jin Z; Cui Y; Dong R; Li L; Lizal F; Hriberšek M; Ravnik J; Yang M; Liu Y
Comput Methods Programs Biomed; 2024 Jun; 251():108203. PubMed ID: 38744057
[TBL] [Abstract][Full Text] [Related]
19. Use of computational fluid dynamics deposition modeling in respiratory drug delivery.
Longest PW; Bass K; Dutta R; Rani V; Thomas ML; El-Achwah A; Hindle M
Expert Opin Drug Deliv; 2019 Jan; 16(1):7-26. PubMed ID: 30463458
[TBL] [Abstract][Full Text] [Related]
20. Characterization of regional and local deposition of inhaled aerosol drugs in the respiratory system by computational fluid and particle dynamics methods.
Farkas A; Balásházy I; Szocs K
J Aerosol Med; 2006; 19(3):329-43. PubMed ID: 17034308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
